Cite
HARVARD Citation
Eshleman, S. et al. (2022). HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention. Journal of infectious diseases. pp. 2170-2180. [Online].